POSEIDA THERAPEUTICS INC (PSTX)

US73730P1084 - Common Stock

9.4  -0.2 (-2.08%)

After market: 9.4101 +0.01 (+0.11%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
150.86M64.70M130.50M31.20M0.00
Operating Expenses
213.36M194.21M190.40M172.60M126.50M
Research and Development
172.43M156.77M152.90M136.70M103.50M
Selling, General, and Administrative Expenses
40.93M37.44M37.50M35.90M23.00M
Operating Income
-62.50M-129.50M-59.90M-141.40M-126.50M
Interest Income/Expense
-9.07M-8.67M-6.40M-3.40M-3.90M
Other Income/Expense
10.86M14.85M2.90M300.00K700.00K
Non Recurring Items
N/AN/AN/A19.50MN/A
Income Before Taxes
-60.72M-123.32M-63.50M-125.00M-129.80M
Income Tax
N/A107.00K500.00K0.000.00
Net Income
-60.76M-123.43M-64.00M-125.00M-129.80M
EBITDA
-57.02M-123.89M-54.73M-136.85M-123.91M
 
Per Share Data
EPS Diluted Total Ops
-0.63-1.37-0.89-2.01-2.10
Non GAAP EPS
-0.63-1.39-1.09-2.02N/A
 
Statistics
Profit Margin
-40.28%-190.76%-49.04%-400.64%N/A
Operating Profit Margin
-41.43%-200.15%-45.90%-453.21%N/A

All data in USD

Charts